HomeATOS • NASDAQ
Atossa Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.04M | 27.23% |
Net income | -8.42M | -39.25% |
Net profit margin | — | — |
Earnings per share | -0.07 | -40.00% |
EBITDA | -9.04M | -27.25% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.86M | -27.25% |
Total assets | 64.52M | -24.86% |
Total liabilities | 6.82M | 19.73% |
Total equity | 57.70M | — |
Shares outstanding | 129.17M | — |
Price to book | 1.68 | — |
Return on assets | -33.42% | — |
Return on capital | -36.74% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -8.42M | -39.25% |
Cash from operations | -7.26M | -60.21% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | — | — |
Net change in cash | -7.26M | -63.71% |
Free cash flow | -4.49M | -59.30% |
Previous close
$0.75
Day range
$0.75 - $0.77
Year range
$0.55 - $1.66
Market cap
100.06M USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
15
